2011
DOI: 10.1007/s10544-011-9601-z
|View full text |Cite
|
Sign up to set email alerts
|

An implantable Fabry-Pérot pressure sensor fabricated on left ventricular assist device for heart failure

Abstract: Continuous flow left ventricular assist devices (LVADs) are commonly used as bridge-to-transplantation or destination therapy for heart failure patients. However, non-optimal pumping speeds can reduce the efficacy of circulatory support or cause dangerous ventricular arrhythmias. Optimal flow control for continuous flow LVADs has not been defined and calls for an implantable pressure sensor integrated with the LVAD for real-time feedback control of pump speed based on ventricular pressure. A MEMS pressure sens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(25 citation statements)
references
References 63 publications
0
25
0
Order By: Relevance
“…Several EFPI-based configurations have been recently presented [21][22][23][24][25][26][27][28]; in addition, EFPI-based medical devices are commercially available [29]. It is possible to combine an EFPI probe with a fiber Bragg grating (FBG) [30,31], acting as temperature sensor in proximity of the EFPI sensor, to provide a dual sensing with cross compensation; such configuration has been proposed in [26][27][28].…”
Section: Introductionmentioning
confidence: 99%
“…Several EFPI-based configurations have been recently presented [21][22][23][24][25][26][27][28]; in addition, EFPI-based medical devices are commercially available [29]. It is possible to combine an EFPI probe with a fiber Bragg grating (FBG) [30,31], acting as temperature sensor in proximity of the EFPI sensor, to provide a dual sensing with cross compensation; such configuration has been proposed in [26][27][28].…”
Section: Introductionmentioning
confidence: 99%
“…Moving forward, additional studies relating the clinical occurrence of ventricular arrhythmias to molecular and physiological shifts within the myocardium will be invaluable in better defining which mechanisms are most strongly implicated in the time-dependent risks of ventricular arrhythmias in VAD-supported hearts. Further device evolution, including inflow cannula modifications [19,63] and inlet pressure control systems that adjust rotor speeds and prevent suction [23,[64][65][66], may reduce the incidence of ventricular arrhythmias among VAD-supported patients. Prospective trials assessing the benefits of de-novo prophylactic ICD placement and the need to replace ICDs in patients free of post-VAD ventricular arrhythmias would be particularly welcome.…”
Section: Resultsmentioning
confidence: 99%
“…139 Recently, another F-P sensor was successfully tested in vitro and proposed for continuous flow left ventricular assist devices (LVAD). 141 The F-P cavity consisted of a biocompatible parylene diaphragm and a silicon mirror fabricated directly on the inlet shell of the LVAD device. Sensor sensitivity (1 mmHg achieved by fringe counting; less than 0.1 mmHg with interpolation), linear range (up to 100 mmHg) and response time (1 ms; limited by the response time of the optical detector and the self-resonance frequency of the parylene-C membrane) meet the requirements of LVAD pressure-sensing systems.…”
Section: Intravascular and Intracardiac Pressurementioning
confidence: 99%
“…Sensor sensitivity (1 mmHg achieved by fringe counting; less than 0.1 mmHg with interpolation), linear range (up to 100 mmHg) and response time (1 ms; limited by the response time of the optical detector and the self-resonance frequency of the parylene-C membrane) meet the requirements of LVAD pressure-sensing systems. 141 Nevertheless, further improvements are mandatory for animal and human testing. In this case, however, authors have pointed the necessary steps to accomplish it.…”
Section: Intravascular and Intracardiac Pressurementioning
confidence: 99%
See 1 more Smart Citation